Skip to main content

Female Infertility

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
Study of the Cleavage of the Egg in Relation to the Stimulation TreatmentN/A1 trial
Active Trials
NCT01674894Completed356Est. Mar 2016
Bharat Serums & Vaccines
1 program
Recombinant Human Follicle Stimulating Hormone 900 IUPHASE_31 trial
Active Trials
NCT05266924Unknown250Est. Nov 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bharat Serums & VaccinesRecombinant Human Follicle Stimulating Hormone 900 IU
Ferring PharmaceuticalsStudy of the Cleavage of the Egg in Relation to the Stimulation Treatment

Clinical Trials (2)

Total enrollment: 606 patients across 2 trials

NCT05266924Bharat Serums & VaccinesRecombinant Human Follicle Stimulating Hormone 900 IU

Recombinant Follicle-stimulating Hormone in Treatment for Infertility

Start: Jul 2022Est. completion: Nov 2023250 patients
Phase 3Unknown
NCT01674894Ferring PharmaceuticalsStudy of the Cleavage of the Egg in Relation to the Stimulation Treatment

Study of the Cleavage of the Egg in Relation to the Stimulation Treatment

Start: Jan 2013Est. completion: Mar 2016356 patients
N/ACompleted

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.